or Try an Advanced Search...

    Technical Analysis for RPHM - Reneo Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    D 1.83 5.17% 0.09
    RPHM closed up 5.17 percent on Wednesday, May 8, 2024, on 2.13 times normal volume.
    Earnings due: May 9
    *** please verify all earnings dates ***
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Up
    Historical RPHM trend table...
    Date Alert Name Type % Chg
    Pocket Pivot Bullish Swing Setup 0.00%
    Wide Range Bar Range Expansion 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Above Upper BB Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Gapped Up Strength 5.17%
    Upper Bollinger Band Touch Strength 5.17%
    Gapped Down Weakness 5.78%
    Spinning Top Other 5.17%
    Gapped Up Strength 5.17%
    Older End-of-Day Signals for RPHM ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 13 hours ago
    Up 2 ATRs about 13 hours ago
    Down 1% about 16 hours ago
    Possible Pocket Pivot about 16 hours ago
    60 Minute Opening Range Breakdown about 16 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    RPHM Chart by TradingView
    Basic chart:

    Profile

    Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. The company was incorporated in 2014 and is headquartered in San Diego, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Clinical Research Clinical Trial Stage Pharmaceutical Transcription Factors Carboxylic Acids Intracellular Receptors

    Is RPHM a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 7 Reneo Pharmaceuticals GAAP EPS of -$0.25
    May 7 Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results
    Mar 28 Reneo Pharmaceuticals GAAP EPS of -$2.52
    Mar 28 Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update
    Mar 25 Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
    Dec 27 Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Dec 21 These Stocks under $10 Are Poised To Explode
    Dec 15 Reneo (RPHM) Plummets 83% on Failure of Metabolic Disorder Study
    Dec 15 5 Analysts Have This to Say About Reneo Pharmaceuticals
    Dec 14 Why Is Genetic Disease Focused Reneo Pharmaceuticals Stock Plummeting Today?
    See more RPHM news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 9.45
    52 Week Low 0.9801
    Average Volume 133,963
    200-Day Moving Average 4.33
    50-Day Moving Average 1.68
    20-Day Moving Average 1.71
    10-Day Moving Average 1.71
    Average True Range 0.07
    RSI (14) 67.53
    ADX 30.38
    +DI 31.97
    -DI 9.86
    Chandelier Exit (Long, 3 ATRs) 1.70
    Chandelier Exit (Short, 3 ATRs) 1.84
    Upper Bollinger Bands 1.80
    Lower Bollinger Band 1.62
    Percent B (%b) 1.16
    BandWidth 10.66
    MACD Line 0.02
    MACD Signal Line 0.01
    MACD Histogram 0.0111
    Fundamentals Value
    Market Cap 60.96 Million
    Num Shares 33.3 Million
    EPS -2.36
    Price-to-Earnings (P/E) Ratio -0.78
    Price-to-Sales 0.00
    Price-to-Book 0.48
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.09
    Resistance 3 (R3) 2.08 1.98 2.04
    Resistance 2 (R2) 1.98 1.92 1.99 2.03
    Resistance 1 (R1) 1.91 1.88 1.95 1.92 2.01
    Pivot Point 1.81 1.81 1.83 1.82 1.81
    Support 1 (S1) 1.74 1.75 1.78 1.75 1.65
    Support 2 (S2) 1.64 1.71 1.65 1.63
    Support 3 (S3) 1.57 1.64 1.62
    Support 4 (S4) 1.58